Back to video list Back to Home Real-World Effectiveness | Dose Response Relationship You may also like Alzheimer's Disease Article β-amyloid remains a compelling target Depression Article Does glutamate hold the key to unlocking major depressive disorder? Schizophrenia Congress highlights Article Schizophrenia and the NMDA receptor – past, present and future Alzheimer's Disease Article Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease?
